RxDoctor Payments DataLook up a doctor →

Gina Chung, MD

Medical Oncology · Cincinnati, OHNPI 1861480543

Payments from drug & device makers

$636,401in general payments, 2019–2025

Across 172 payments — averaging $3700.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$293K
  • AstraZeneca$289K
  • Veru Inc.$22K
  • Astrazeneca UK Limited$16K
  • Amgen$7K
  • Pfizer$7K
  • plus $3K from 39 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$636,401 in reported general payments places this provider in the 75th percentile of 157 medical oncology providers in Ohio.

See all medical oncology providers in Ohio

Medicare billing

Part B allowed, 2024
$761,666
Medicare patients
359
Services billed
51,452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →